Biotech companies aim to create value by pushing the boundaries of science, developing new cures or offering more cost-effective treatments for pressing health issues. As these challenges grow in complexity and markets become increasingly global, international R&D has become the norm. Maximizing innovation incentives across multiple tax regimes is critical to sustaining this progress. This […]


